Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM)

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class: Equity / Common Stock, $0.001 par value
Shares outstanding: 2,850,581
Number of holders: 10
Total 13F shares, excl. options: 1,153,141
Shares change: +1,153,141
Total reported value, excl. options: $2,826,000
Value change: +$2,826,017
Number of buys: 10
Price: $2.45

Significant Holders of Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) as of Q1 2022

11 filings reported holding SBFM - Sunshine Biopharma Inc. - Common Stock, $0.001 par value as of Q1 2022.
Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,153,141 shares of 2,850,581 outstanding shares and own 40.45% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (635,002 shares), Empery Asset Management, LP (450,450 shares), GEODE CAPITAL MANAGEMENT, LLC (20,179 shares), Virtu Financial LLC (13,963 shares), TWO SIGMA SECURITIES, LLC (13,047 shares), JANE STREET GROUP, LLC (12,640 shares), Tower Research Capital LLC (TRC) (4,085 shares), UBS Group AG (2,433 shares), NATIONAL BANK OF CANADA /FI/ (1,042 shares), and SIGNATUREFD, LLC (300 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.